Microglial responses to amyloid β peptide opsonization and indomethacin treatment

Journal of Neuroinflammation

Volumn 2, Issue , 2005, Pages

  Strohmeyer, Ronald ^a   Kovelowski, Carl J ^a   Mastroeni, Diego ^a   Leonard, Brian ^a   Grover, Andrew ^a   Rogers, Joseph ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; IMMUNOGLOBULIN G; INDOMETACIN; INTERLEUKIN 6; MONOCLONAL ANTIBODY; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CELL CULTURE; CELLULAR IMMUNITY; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNIZATION; IN VITRO STUDY; INFLAMMATION; MICROGLIA; OPSONIZATION; PHAGOCYTOSIS; PROTEIN SYNTHESIS INHIBITION;

EID: 27344447969     PISSN: 17422094     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-2-18     Document Type: Article

References (32)

1. Luber-Narod J. Rogers J: Immune system associated antigens expressed by cells of the human central nervous system. Neurosci Lett 1988, 94:17-22.
2. Rogers J. Luber-Narod J. Styren SD, Civin WH: Expression of Immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988, 9:339-349.
3. Terry RD, Wisnlowski HM: Structural and chemical changes of the aged human brain. Psychopharmacol Bull 1975, 11-46-63.
4. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E, Esler WP, Meggio JE, Mantyh PW: Fibrillar beta-amyloid Induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998. 18:2161-2173.
5. Ard MD. Cole GM, Wei J. Mehrle AP, Fratkin JD: Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res 1996, 43:190-202.
6. Bard F, Cannon C, Barbour R, Burke RL, Games D. Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko, D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D. Yednock T: Peripherally administered antibodies against amylold beta-peptide enter the central nervous system and reduce pathology In a mouse model of Alzheimer disease. Nat Med 2000, 6:916-919.
7. Bard F, Barbour R, Cannon C, Carretto R, Fox M, Games D, Guido T. Hoenow K, Hu K, Johnson-Wood K, Khan K, Kholodenko, D. Lee C, Lee M, Motter R, Nguyen M, Read A, Schenk D. Tang P, Vasquez N, Seubert P, Yednock T: Epitope and isotype specificities of antibodies to beta - amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci U S A 2003, 100:2023-2028.
8. Schenk DB, Yednock T: The role of microglia In Alzheimer's disease: friend or foe? Neurobiol Aging 2002, 23:677-679.
9. McGeer EG, McGeer PL: Clinically tested drugs for Alzheimer's disease. Expert Opin Investig Drugs 2003, 12:1143-1151.
10. McGeer EG, McGeer PL: Brain Inflammation In Alzheimer's disease and the therapeutic implications. Curr Pharm Der 1999, 5:821-836.
11. Lue LF, Brachova L, Walker DG, Rogers J: Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol Aging 1996, 17:421-429.
12. Lue LF, Rydel R, Brigham EF, Yang LB, Hampel H, Murphy GM Jr, Brachova L, Yan SD, Walker DG, Shen Y, Rogers J: Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glio 2001. 35:72-79.
13. Bruguerolle, B, Barbeau G, Belanger PM, Labrecque G: Pharmacokinetics of a sustained-release product of Indomethacin in the elderly. Gerontology 1986, 32:277-285.
14. Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol 1996, 55:1083-1088.
15. Lue LF, Walker DG, Brachova L, Beech TG, Rogers J, Schmidt AM, Stern DM, Yan SD: Involvement of microglial receptor for advanced glycation endproducts (RAGE) In Alzheimer's disease: Identification of a cellular activation mechanism. Exp Neurol 2001, 171:29-45.
16. Honda M, Akiyama H, Yamada Y, Kondo H, Kawabe Y, Takeya M, Takahashi K, Suzuki H, Doi T, Sakamoto A, Ookawara S, Mato M, Gough PJ, Greaves DR, Gordon S, Kodama T, Matsushita M: Immunohistochemical evidence for a macrophage scavenger receptor In Mato calls and reactive microglia of Ischemia and Alzheimer's disease. Biochem Biophys Res Commun 1998, 245:714-740.
17. Christie RH, Freeman M, Hyman BT: Expression of the macrophase scavenger receptor, a multifunctional lipoprotein receptor, In microglia associated with senile plaques in Alzheimer's disease. Am J Pathol 1996, 148:399-403.
18. El Khoury J, Hickman SE, Thomas CA, Cao L, Silverstein SC, Loike JD; Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature 1996, 382:716-719.
19. Lorton D, Schaller J, Lala A. DeNardin E: Chemotactic-like receptors and Abeta peptide induced responses in Alzheimer's disease. Neurobiol Aging 2000, 21:463-473.
20. Koenigsknocht J, Landreth G: Microglial phagocytosis of fibrillar beta-amyloid through a betal Integrin-dependent mechanism. J Neurosci 2004, 24:9838-9846.
21. Bourin M, Ripoll N, Dailly E: Nicotinic receptors and Alzheimer's disease. Curr Med Res Opin 2003, 19:169-177.
22. Cole GM, Beech W, Frautschy SA, Sigel J, Glasgow C, Ard MD: Lipo-protein effects on Abeta accumulation and degradation by microglia in vitro. J Neurosci Res 1999, 57:504-520.
23. Wisniewski HM, Terry RD: Morphology of the aging brain, human and animal. Prog Brain Res 1973, 40:167-186.
24. Banati RB, Gehrmann J, Czech C, Monning U, Jones LL, Konig G, Beyreuther K, Kreutzberg GW: Early and rapid de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) In activated microglia. Glio 1993, 9:199-210.
25. Ito S, Sawada M, Haneda M, Fujil S, Oh-Hashi K, Kiuchl K, Takahashi M, Isobe K: Amyloid-beta peptides Induce cell proliferation and macrophage colony-stimulating factor expression via the P13-kinase/Akt pathway in cultured Ra2 microglial cells. FEBS Lett 2005, 579:1995-2000.
26. Floden AM, U S, Combs CK: Beta-amyloid-stimulated microglia Induce neuron deal via synergistic stimulation of tumor nacrosis factor alpha and NMDA receptors. J Neurosci 2005, 25:2566-2575.
27. Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration, Neurobiol Aging 2005, 26:349-354.
28. LI R, Strohmeyer R, Liang Z, Lue LF, Rogers J: CCAAT/enhancer binding protein delta (C/EBP delta) expression and elevation In Alzheimer's disease. Neurobiol Aging 2004, 25:991-999.
29. Bales KR, Du Y. Holtzman D, Cordell B. Paul SM: Neuroinflammation and Alzheimer's disease: critical roles for cytokine/Abeta-Induced glial activation, NF-kappaB, and apolipoprotein E. Neurobiol Aging 2000, 21:427-430.
30. Masliah E, Hansen L, Bard F, Lee C, Seubert P, Games D, Kirby L, Schank D: Aβ vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer's disease. Neurology 2005, 64:129-131.
31. DeMattos RB, Balas KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM: Peripheral anti-Abeta antibody alters CNS and plasma Abeta-clearance and decreases brain Abeta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 2001, 98:8850-8855.
32. Song X, Tanaka S, Cox D, Lee SC: Fegamma receptor signaling in primary human microglia: differential roles of PI-3K and Ras/ERK MAPK pathways in phagocytosis and chemokine Induction. J Leukoc Biol 2004, 75:1147-1155.